Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System

References

• Abchowski A., McCoy J. R., Palczuk N. C., van Es T., Davis F. F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 1977; 252: 3582–3586
   PubMed Web of Science ®Google Scholar
• Cummings J., Merry S., Willmott N. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyglycones in AKR mice bearing a sub-cutaneously growing ridg-way osteogenic sarcoma (ROS). Eur. J. Cancer Clin. Oncol. 1986; 22: 451–460
   PubMedGoogle Scholar
• de Leeuw A. M., Brouwer A., Knook D. L. Sinusoidal endothelial cells of the liver: Fine structure and function in relation to age. J. Electron Microscopy Technique 1990; 14: 218–236
   PubMedGoogle Scholar
• Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 1995; 146: 1029–1039
   PubMed Web of Science ®Google Scholar
• Duncan R., Dimitrijevic S., Evagorou E. G. The role of polymer conjugates in the diagnosis and treatment of cancer. S. T. P. Pharma. Sci. 1996; 6: 237–263
   Web of Science ®Google Scholar
• Forssen E. A., Coulter D. M., Proffitt R. T. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res. 1992; 52: 3255–3261
   PubMed Web of Science ®Google Scholar
• Gabizon A., Price D. C., Huberty J., Bresalier R. S., Papahadjopoulos D. Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies. Cancer Res. 1990; 50: 6371–6378
   PubMed Web of Science ®Google Scholar
• Huang S. K., Mayhew E., Gilani S., Lasic D. D., Martin F. J., Papahadjopoulos D. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon tumor. Cancer Res. 1992; 52: 6774–6781
   PubMed Web of Science ®Google Scholar
• Kabanov A. V., Batrakova E. V., Melik-Nubarov Fedoseev N. A., Dorodnich T. Y., Alakhov V. Y., Chekhonin V. P., Nazarova I. R., Kabanov V. A.A. A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J. Contr. Rel. 1992; 22: 141–158
   Web of Science ®Google Scholar
• Katre N. V., Knauf M. J., Laird W. J. Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. (USA) 1987; 84: 1487–1491
   PubMed Web of Science ®Google Scholar
• Kohn S., Nagy J. A., Dvorak H. F., Dvorak A. M. Pathways of macromolecular tracer transport across venules and small veins: Structural basis for the hyperpermeability of tumor blood vessels. Lab. Invest. 1992; 67: 596–607
   PubMed Web of Science ®Google Scholar
• Kopccck J., Rejmanova P., Chytry V. Polymers containing enzymatically degradable bonds, 1. Chymotrypsin catalysed hydrolysis of p-nitroanilides of phenylalanine and tyrosine attached to side-chains of copolymers of N-(2-hydroxy-propyl)methacrylamide. Makromol. Chem. 1981; 182: 799–801
   Web of Science ®Google Scholar
• Kwon G. S., Yokoyama M., Okano T., Sakurai S., Kataoka K. Biodistribution of micelle-forming polymer-drug conjugates. Pharm. Res. 1993; 10: 970–974
   PubMed Web of Science ®Google Scholar
• Kwon G. S., Yokoyama M., Okano T., Sakurai S., Kataoka K. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Contr. Rel. 1994a; 29: 17–23
   Web of Science ®Google Scholar
• Kwon G. S., Naito M., Kataoka K., Yokoyama M., Sakurai Y., Okano T. Block copolymer micelles as vehicles for hydrophobic drugs. Colloids and Surfaces B: Biointerfaces 1994b; 2: 429–434
   Web of Science ®Google Scholar
• Kwon G. S., Naito M., Kataoka K., Yokoyama M., Okano T., Sakurai Y. Physical entrapment of doxorubicin in AB block copolymer micelles. Pharm. Res. 1995; 12: 192–195
   PubMed Web of Science ®Google Scholar
• Kwon G. S., Naito M., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Block copolymer micelles for drug delivery: Loading and release of doxorubicin. J. Contr. Rel. 1997; 48: 195–201
   Web of Science ®Google Scholar
• Lasic D. D., Martin F. J., Gabizon A., Huang S. K., Papahadjopoulos D. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta 1991; 1070: 187–192
   PubMed Web of Science ®Google Scholar
• Litzinger D. C., Buiting A. M.J., van Roojen N., Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta 1994; 1190: 99–107
   PubMed Web of Science ®Google Scholar
• Maeda H., Seymour L. W., Miyamoto Y. Conjugates of anticancer agents and polymers: Advantages of macromolec-ular therapeutics in vivo. Bioconjugate Chem. 1992; 3: 351–362
   PubMed Web of Science ®Google Scholar
• Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986; 46: 6387–6392
   PubMed Web of Science ®Google Scholar
• McCready D. R., Balch C. M., Fidler I. J., Murray J. L. Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo. J. Natl. Cancer. Inst. 1989; 81: 682–687
   PubMed Web of Science ®Google Scholar
• Pai L. H., Wittes R., Setser A., Willingham M. C., Pastan I. Treatment of advanced tumors with immunotoxin LMB-1: An antibody linked Pseudomonas exotoxin. Nature Medicine 1996; 2: 350–353
   PubMed Web of Science ®Google Scholar
• Putnam D., Kopecek J. Polymer conjugates with anticancer activity. Adv. Polym. Sci. 1995; 122: 55–123
   Web of Science ®Google Scholar
• Rolland A., O'mullane J., Goddard P., Brookman L., Petrak K. New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-iso-prene-b-oxyethylene) block copolymer aggregates. J. Appl. Polym. Sci. 1992; 44: 1195–1203
   Web of Science ®Google Scholar
• Senger D. R., Galli S. J., Dvorak A. M., Perruzzi C. A., Harvey V. S., Dvorak H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983–985
   PubMed Web of Science ®Google Scholar
• Seymour L. W., Miyamoto Y., Maeda H., Brereton M., Strohalm J., Ulbrich K., Duncan R. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur. J. Cancer 1995; 31A: 766–770
   PubMed Web of Science ®Google Scholar
• Tardi P. G., Boman NX., Cullis P. R. Review: Liposomal doxorubicin. J. Drug Targeting 1996; 4: 129–140
   PubMed Web of Science ®Google Scholar
• Tomlinson E. (Paso)physiology and the temporal and spatial aspects of drug delivery. Site-Specijic Drug Delivery, E. Tomlinson, S. S. Davis. Wiley & Sons Ltd. 1986; 1–26
   Google Scholar
• Trail P. A., Wilner D., Lasch S. J., Henderson A. J., Hofstead H., Casazza A. M., Firestone R. A., Hellström I., Hellström K. E. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 1993; 261: 212–215
   PubMed Web of Science ®Google Scholar
• Wish L., Furth J., Storey R. H. Direct determinations of plasma, cell, and organ-blood volumes in normal and hypervolemic mice. Proc. Soc. Exp. Biol. And Med. 1950; 74: 644–648
   PubMed Web of Science ®Google Scholar
• Woodle M. C., Lasic D. D. Sterically stabilized liposomes. Biochim. Biophys. Acta 1992; 1113: 171–199
   PubMed Web of Science ®Google Scholar
• Yesair D. W., Schwartzbach E., Shunk D., Denine E. P., Asbell M. A. Comparative pharamacokinetics of daunomycin and adriamycin in several animal species. Cancer Res. 1972; 32: 1177–1183
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Miyauchi M., Yamada N., Okano T., Sakurai Y., Kataoka K., Inoue S. Characterization and anticancer activity of the micelle-forming polymeric anticancer drug doxorubicin-conjugated poly(ethylene glycol)-poly (aspartic acid) block copolymer. Cancer Res. 1990; 50: 1693–1700
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Okano T., Sakurai Y., Ekimoto H., Shibazaki C., Kataoka K. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 1991; 51: 3229–3236
   PubMed Web of Science ®Google Scholar
• Yokoyama M., Kwon G. S., Okano T., Sakurai Y., Ekimoto H., Okamoto K., Mashiba H., Seto T., Kataoka K. Composition-dependent in vivo antitumor activity of doxorubicin-conjugated polymeric micelle against murine colon adenocarcinoma 26. Drug Delivery 1993; 1: 11–19
   Google Scholar
• Yokoyama M., Okano T., Sakurai Y., Kataoka K. Improved synthesis of doxorubicin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal miceilar structure with controlled amount of physically entrapped doxorubicin. J. Contr. Rel. 1994; 32: 269–277
   Web of Science ®Google Scholar
• Yokoyama M., Okano T. Targetable drug carriers: Present status and a future perspective. Adv. Drug Delivery Rev. 1997; 21: 77–80
   Web of Science ®Google Scholar
• Yokoyama M., Fukushima S., Vehara R., Okamoto K., Kataoka K., Sakurai Y., Okano T. Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and thier design for in vivo delivery to a solid tumor. J. Contr. Rel. 1998; 50: 79–92
   PubMed Web of Science ®Google Scholar